141 related articles for article (PubMed ID: 9142639)
1. Immunohistochemical evidence of insulin-like growth factor II in human small hepatocellular carcinoma with hepatitis C virus infection: relationship to fatty change in carcinoma cells.
Sohda T; Kamimura S; Iwata K; Shijo H; Okumura M
J Gastroenterol Hepatol; 1997 Mar; 12(3):224-8. PubMed ID: 9142639
[TBL] [Abstract][Full Text] [Related]
2. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
[TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
Seo JH; Park BC
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
Park BC; Huh MH; Seo JH
J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
6. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
Seo JH; Kim KW; Murakami S; Park BC
J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study.
Chun YS; Huang M; Rink L; Von Mehren M
World J Surg Oncol; 2014 Jul; 12():231. PubMed ID: 25052889
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: an immunohistochemical study.
D'Errico A; Grigioni WF; Fiorentino M; Baccarini P; Lamas E; De Mitri S; Gozzetti G; Mancini AM; Brechot C
Pathol Int; 1994 Feb; 44(2):131-7. PubMed ID: 8025652
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
[TBL] [Abstract][Full Text] [Related]
10. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
[TBL] [Abstract][Full Text] [Related]
11. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
12. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
13. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
14. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
15. Big insulin-like growth factor II-producing hepatocellular carcinoma associated with hypoglycemia.
Ishida S; Noda M; Kuzuya N; Kubo F; Yamada S; Yamanaka T; Isozaki O; Hizuka N; Kanazawa Y
Intern Med; 1995 Dec; 34(12):1201-6. PubMed ID: 8929651
[TBL] [Abstract][Full Text] [Related]
16. The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment.
Espelund U; Grønbæk H; Villadsen GE; Simonsen K; Vestergaard PF; Jørgensen JO; Flyvbjerg A; Vilstrup H; Frystyk J
Growth Horm IGF Res; 2015 Aug; 25(4):174-81. PubMed ID: 26068014
[TBL] [Abstract][Full Text] [Related]
17. Co-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cells.
Sohda T; Oka Y; Iwata K; Gunn J; Kamimura S; Shijo H; Okumura M; Yun K
J Clin Pathol; 1997 Feb; 50(2):135-7. PubMed ID: 9155694
[TBL] [Abstract][Full Text] [Related]
18. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis].
Fan Z; Yang D; Qin H
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):84-6. PubMed ID: 10861110
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.
Qian J; Yao D; Dong Z; Wu W; Qiu L; Yao N; Li S; Bian Y; Wang Z; Shi G
Am J Clin Pathol; 2010 Nov; 134(5):799-806. PubMed ID: 20959664
[TBL] [Abstract][Full Text] [Related]
20. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.
Rashad NM; El-Shal AS; Abd Elbary EH; Abo Warda MH; Hegazy O
Cytokine; 2014 Jul; 68(1):50-8. PubMed ID: 24656929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]